Table 2 Intraoperative data
Neostigmine group (n = 34) | Sugammadex group (n = 36) | |
|---|---|---|
Type of anesthesia | ||
Total intravenous anesthesia | 27 (79.4%) | 30 (83.3%) |
Balanced inhaled anesthesia | 7 (20.6%) | 6 (16.7%) |
Rocuronium dose at induction (mg) | 50 (40–50) | 50 (40–50) |
Number of additional doses of rocuronium administered | 3 (2–4) | 4 (2–5) |
Additional dosage of rocuronium administered (mg) | 22 (20–40) | 35 (20–60) |
Total rocuronium dose (mg) | 70 (60–90) | 76 (60–115) |
Neostigmine dose (mg) | 3.5 (3.0–4.0) | - |
Neostigmine dose (mg/kg) | 0.05 (0.048–0.05) | - |
Atropine dose (mg/kg) | 0.02 (0.019–0.021) | - |
Sugammadex dose (mg) | - | 150 (140–180) |
Sugammadex dose (mg/kg) | - | 2.02 (2.00–2.11) |
Length of anesthesia (min) | 196 (147–227) | 192 (142–240) |
Length of surgery (min) | 122 (76–154) | 108 (80–146) |
Surgical technique | ||
Thoracotomy | 13 (38.2%) | 13 (36.1%) |
Video-assisted thoracoscopy | 21 (61.7%) | 23 (63.9%) |
Side of surgery (right) | 19 (55.9%) | 23 (63.9%) |
Type of surgery | ||
Major resection | 12 (33.3%) | 19 (52.8%) |
Minor resection | 22 (66.7%) | 17 (47.2%) |